Answers are grounded in this paper and cite their sources.
A case report shows effective diagnosis of grade 3 LYG through robotic-assisted bronchoscopy, highlighting treatment challenges.
Lymphomatoid granulomatosis (LYG) is a rare, Epstein–Barr virus (EBV)–associated lymphoproliferative disorder characterized by angiocentric and angiodestructive infiltrates that most commonly involve the lungs. We report a case of a 38‐year‐old female with a history of latent tuberculosis who presented with a 3‐day history of fever, productive cough, bilateral lower extremity edema, and painless lower extremity skin lesions. Initial imaging revealed bilateral pulmonary nodules, and an extensive infectious workup was unrevealing. To obtain diagnostic tissue from peripheral lesions, she underwent robotic‐assisted bronchoscopy with targeted transbronchial biopsy. Histopathologic analysis revealed angiocentric and angiodestructive infiltrates with EBV positivity in CD20‐positive B cells, consistent with Grade 3 LYG. She was treated with dose‐adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (DA‐EPOCH‐R) chemotherapy, with initial radiographic response. However, she later developed refractory LYG complicated by hemophagocytic lymphohistiocytosis (HLH) and died of progressive disease. Robotic‐assisted bronchoscopy enabled safe, targeted sampling of peripheral pulmonary nodules, avoiding more invasive surgical biopsy.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: